Randomized Phase IIa Trial of Purified Candida Antigen for Common Warts: Evaluating the Safety and Efficacy Across Multiple Dosing Regimens

Abstract Introduction Non-standardized Candida albicans antigens are commonly used for the treatment of common warts (verruca vulgaris); however, clinical studies thus far have not determined optimal dosing. This study assessed three dosing schemes using Candin®, a standardized purified Candida anti...

Full description

Saved in:
Bibliographic Details
Main Authors: Stacy R. Smith, Robert E. Esch, H. S. Nielsen, Sandra Marchese Johnson
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-03-01
Series:Dermatology and Therapy
Subjects:
Online Access:https://doi.org/10.1007/s13555-025-01387-1
Tags: Add Tag
No Tags, Be the first to tag this record!